Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Enanta Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities and Carry Forward Securities
| Security Type(1) |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered(1)(2) |
Proposed Maximum Offering Price Per Unit(2) |
Maximum Price |
Fee Rate |
Amount of Registration Fee | |||||||||
| Newly Registered Securities | ||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.01 per share | — | — | — | — | — | — | ||||||||
| Equity | Preferred Stock, par value $0.01 per share | — | — | — | — | — | — | |||||||||
| Debt | Debt Securities | |||||||||||||||
| Other | Warrants | — | — | — | — | — | — | |||||||||
| Other | Units(3) | — | — | — | — | — | — | |||||||||
| Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 457(o) | (1)(2) | (2) | $150,000,000 | 0.00014760 | $22,140 | |||||||||
| Carry Forward Securities | ||||||||||||||||
| Carry Forward Securities | — | — | — | — | — | — | — | — | ||||||||
| Total Offering Amounts | $150,000,000 | 0.00014760 | $22,140 | |||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | $9,270 | |||||||||||||||
| Net Fee Due | $12,870 | |||||||||||||||
| (1) | This registration statement covers such indeterminate amount or number of the securities of each identified class as the registrant may from time to time issue at indeterminate prices which shall have an aggregate initial offering price not to exceed $150,000,000, including securities issuable upon conversion, exercise, exchange, redemption, repurchase or settlement of other securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement shall also cover any additional securities issuable by reason of any stock split, stock dividend or similar transaction, including anti-dilution provisions. |
| (2) | The proposed maximum offering price per unit for the primary offering will be determined, from time to time, by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act. |
| (3) | Each unit will represent an interest in two or more other securities, which may or may not be separable from one another. |
Table 2: Fee Offset Claims and Sources
| Registrant or Filer Name |
Form or Filing Type |
File Number |
Initial Filing Date |
Filing Date |
Fee Offset Claimed |
Security Type Associated with Fee Offset Claimed |
Security Title Associated with Fee Offet Claimed |
Unsold Securities Associated with Fee Offset Claimed |
Aggregate Amount with Fee Offset Claimed |
Fee Paid with Fee | ||||||||||||
| Rule 457(p) | ||||||||||||||||||||||
| Fee Offset Claims | Enanta Pharmaceuticals, Inc. | 424(b)(5) | 333-258632 | August 26, 2022 | — | $9,270 (1) | Equity | Common Stock, par value $0.01 per share | (1) | $100,000,000 | ||||||||||||
| Fee Offset Sources | Enanta Pharmaceuticals, Inc. | 424(b)(5) | 333-258632 | August 26, 2022 | $9,270 | |||||||||||||||||
| (1) | On August 26, 2022, the registrant filed a prospectus supplement (the “2022 Prospectus Supplement”) to the prospectus included in its Registration Statement on Form S-3 (Registration Statement No. 333-258632) (the “2021 Registration Statement”) and concurrently submitted a fee of $9,270. The 2022 Prospectus Supplement related to the registrant’s offer and sale from time to time of shares of the registrant’s common stock, par value $0.01 per share, having an aggregate gross sales price of up to $100,000,000 from time to time under an at-the-market program. As of the date of this registration statement, the full $100,000,000 remains unsold under the at-the-market program. The 2021 Registration Statement and the offering that included the unsold securities under the 2022 Prospectus Supplement have been terminated. Pursuant to Rule 457(p) under the Securities Act, a registration fee credit of $9,270 is available to offset the current registration fee. |